• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型吡唑苯并咪唑酮衍生物作为强效抗氧化剂的设计、合成、分子建模及生物学评价

Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants.

作者信息

Adardour Mohamed, Ait Lahcen Marouane, Oubahmane Mehdi, Ettahiri Walid, Hdoufane Ismail, Bouamama Hafida, Alanazi Mohammed M, Cherqaoui Driss, Taleb Mustapha, Garcia Elena Zaballos, Baouid Abdesselam

机构信息

Molecular Chemistry Laboratory, Department of Chemistry, Semlalia Faculty of Sciences, 2390, Cadi Ayyad University, Marrakech 40001, Morocco.

Laboratory of Engineering, Electrochemistry, Modeling and Environment, Faculty of Sciences, Sidi Mohamed Ben Abdellah University, Fez 30000, Morocco.

出版信息

Pharmaceuticals (Basel). 2023 Nov 24;16(12):1648. doi: 10.3390/ph16121648.

DOI:10.3390/ph16121648
PMID:38139775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10747449/
Abstract

In the present study, we used benzimidazolone as a starting material to efficiently synthesize several hybrid compounds of pyrazole benzimidazolone derivatives by the 1,3-dipolar cycloaddition reaction. These compounds were obtained in average yields and were characterized by NMR (H and C) and HRMS analysis. The antioxidant activity of the synthesized compounds (-) and (-) was evaluated using in vitro reduction assays, including ferric reducing antioxidant power (FRAP) and total antioxidant capacity (TAC). The results indicated that products , , and exhibit higher antioxidant activity compared to the reference compounds and showed a remarkable ability to effectively remove the radical at IC (14.00 ± 0.14, 12.47± 0.02, and 12.82 ± 0.10 µM, respectively) under the TAC assessment. Conversely, compound showed excellent activity at IC (68.97 ± 0.26 µM) in the FRAP assay. We carried out molecular docking and dynamics simulations to investigate the binding mode and stability of , , and in the active site of human Peroxiredoxin 5. An ADMET study was conducted to determine the drug properties of the synthesized compounds.

摘要

在本研究中,我们以苯并咪唑酮为起始原料,通过1,3 - 偶极环加成反应高效合成了几种吡唑苯并咪唑酮衍生物的杂化化合物。这些化合物的平均产率较高,并通过核磁共振(氢谱和碳谱)和高分辨质谱分析进行了表征。使用体外还原试验,包括铁还原抗氧化能力(FRAP)和总抗氧化能力(TAC),对合成化合物(-)和(-)的抗氧化活性进行了评估。结果表明,与参考化合物相比,产物、和表现出更高的抗氧化活性,并且在TAC评估下,在IC(分别为14.00±0.14、12.47±0.02和12.82±0.10μM)时显示出有效清除自由基的显著能力。相反,化合物在FRAP试验中在IC(68.97±0.26μM)时表现出优异的活性。我们进行了分子对接和动力学模拟,以研究、和在人过氧化物还原酶5活性位点的结合模式和稳定性。进行了ADMET研究以确定合成化合物的药物性质。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/0c77d31fa2e0/pharmaceuticals-16-01648-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/e92fa5ba62dd/pharmaceuticals-16-01648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/87c0c4c0bd5f/pharmaceuticals-16-01648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/fc49ea2583df/pharmaceuticals-16-01648-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/8bee3fd46443/pharmaceuticals-16-01648-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/01ec770b3d54/pharmaceuticals-16-01648-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/19793ce217a9/pharmaceuticals-16-01648-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/0c77d31fa2e0/pharmaceuticals-16-01648-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/e92fa5ba62dd/pharmaceuticals-16-01648-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/87c0c4c0bd5f/pharmaceuticals-16-01648-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/fc49ea2583df/pharmaceuticals-16-01648-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/8bee3fd46443/pharmaceuticals-16-01648-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/01ec770b3d54/pharmaceuticals-16-01648-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/19793ce217a9/pharmaceuticals-16-01648-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6131/10747449/0c77d31fa2e0/pharmaceuticals-16-01648-g005.jpg

相似文献

1
Design, Synthesis, Molecular Modeling and Biological Evaluation of Novel Pyrazole Benzimidazolone Derivatives as Potent Antioxidants.新型吡唑苯并咪唑酮衍生物作为强效抗氧化剂的设计、合成、分子建模及生物学评价
Pharmaceuticals (Basel). 2023 Nov 24;16(12):1648. doi: 10.3390/ph16121648.
2
Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors.新型 3-(2-萘基)-1-苯基-1H-吡唑衍生物的设计、合成、分子模拟及作为有效抗氧化剂和 15-脂氧合酶抑制剂的生物评价。
J Enzyme Inhib Med Chem. 2020 Dec;35(1):847-863. doi: 10.1080/14756366.2020.1742116.
3
Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.靶向VEGFR-2酶的新型三唑并[3,4-a]酞嗪衍生物的设计、合成、体外抗癌活性、ADMET特性及分子对接
Anticancer Agents Med Chem. 2018;18(8):1184-1196. doi: 10.2174/1871520618666180412123833.
4
In Silico Design, Synthesis of Hybrid Combinations: Quercetin Based MAO Inhibitors with Antioxidant Potential.计算机辅助设计、混合组合的合成:基于槲皮素的 MAO 抑制剂与抗氧化潜力。
Curr Top Med Chem. 2019;19(2):156-170. doi: 10.2174/1568026619666190212122403.
5
Design, synthesis, in silico ADMET, docking, and antiproliferative evaluations of [1,2,4]triazolo[4,3-c]quinazolines as classical DNA intercalators.设计、合成、计算机 ADMET、对接和[1,2,4]三唑并[4,3-c]喹唑啉类化合物作为经典 DNA 嵌入剂的抗增殖评价。
Arch Pharm (Weinheim). 2022 Apr;355(4):e2100412. doi: 10.1002/ardp.202100412. Epub 2022 Jan 10.
6
Synthesis, characterization, DFT calculation, antioxidant activity, ADMET and molecular docking of thiosemicarbazide derivatives and their Cu (II) complexes.硫代卡巴肼衍生物及其 Cu(II)配合物的合成、表征、DFT 计算、抗氧化活性、ADMET 和分子对接。
Chem Biol Interact. 2022 Jan 5;351:109742. doi: 10.1016/j.cbi.2021.109742. Epub 2021 Nov 11.
7
Synthesis, Characterization and Biological Evaluation of Indole-Pyrazole Amalgamated α-Cyano Substituted Chalcones.吲哚-吡唑杂合的α-氰基取代查尔酮的合成、表征及生物评价。
Anticancer Agents Med Chem. 2021 Oct 28;21(16):2216-2223. doi: 10.2174/1871520621666210201095030.
8
Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.2-氯-7-环戊基-7H-吡咯并[2,3-d]嘧啶衍生物抗乳腺癌的分子动力学与生物学评价
Comb Chem High Throughput Screen. 2017;20(8):703-712. doi: 10.2174/1386207320666170724110015.
9
Design, synthesis, in silico toxicity prediction, molecular docking, and evaluation of novel pyrazole derivatives as potential antiproliferative agents.新型吡唑衍生物作为潜在抗增殖剂的设计、合成、计算机毒性预测、分子对接及评估
EXCLI J. 2016 Mar 1;15:187-202. doi: 10.17179/excli2016-103. eCollection 2016.
10
Synthesis, Antioxidant, Cytotoxicity, Induce Apoptosis Investigation and Docking Study of New Halogenated Dihydropyrano[3,2-]Chromene-3-Carbonitrile Derivatives on MCF-7 Breast Cancer Cell Line.新型卤代二氢吡喃并[3,2-]色烯-3-腈衍生物对MCF-7乳腺癌细胞系的合成、抗氧化、细胞毒性、诱导凋亡研究及对接研究
Iran J Pharm Res. 2023 Apr 18;22(1):e132932. doi: 10.5812/ijpr-132932. eCollection 2023 Jan-Dec.

引用本文的文献

1
Benzimidazole-Pyrimidine Hybrids: Synthesis and Medicinal Properties.苯并咪唑 - 嘧啶杂化物:合成与药用特性
Pharmaceuticals (Basel). 2025 Aug 19;18(8):1225. doi: 10.3390/ph18081225.
2
Novel Crown Ether-Functionalized Fusidic Acid Butyl Ester: Synthesis, Biological Evaluation, In Silico ADMET, and Molecular Docking Studies.新型冠醚功能化夫西地酸丁酯:合成、生物学评价、计算机辅助药物代谢动力学及分子对接研究
Molecules. 2025 May 2;30(9):2033. doi: 10.3390/molecules30092033.

本文引用的文献

1
Biological Evaluation of Xanthene and Thioxanthene Derivatives as Antioxidant, Anticancer, and COX Inhibitors.氧杂蒽和硫杂蒽衍生物作为抗氧化剂、抗癌剂和COX抑制剂的生物学评价
ACS Omega. 2023 Oct 3;8(41):38597-38606. doi: 10.1021/acsomega.3c05695. eCollection 2023 Oct 17.
2
Design and synthesis of neoteric benzylidene amino-benzimidazole scaffolds for antioxidant and anti-inflammatory activity.用于抗氧化和抗炎活性的新型亚苄基氨基苯并咪唑支架的设计与合成
Future Med Chem. 2023 Jun 23. doi: 10.4155/fmc-2023-0058.
3
Design, synthesis, molecular docking and biological evaluation of new carbazole derivatives as anticancer, and antioxidant agents.
新型咔唑衍生物作为抗癌和抗氧化剂的设计、合成、分子对接及生物学评价
BMC Chem. 2023 Jun 16;17(1):60. doi: 10.1186/s13065-023-00961-y.
4
Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations.利用定量构效关系建模、分子对接和分子动力学模拟设计靶向严重急性呼吸综合征冠状病毒2主要蛋白酶的强效抑制剂
Pharmaceuticals (Basel). 2023 Apr 18;16(4):608. doi: 10.3390/ph16040608.
5
Synthesis, characterization, X-ray, α-glucosidase inhibition and molecular docking study of new triazolic systems based on 1,5-benzodiazepine 1,3-dipolar cycloaddition reactions.基于 1,5-苯并二氮杂环 1,3-偶极环加成反应的新型三唑系统的合成、表征、X 射线、α-葡萄糖苷酶抑制和分子对接研究。
J Biomol Struct Dyn. 2024 Feb-Mar;42(4):1985-1998. doi: 10.1080/07391102.2023.2203263. Epub 2023 Apr 26.
6
Waste to drugs: identification of pyrolysis by-products as antifungal agents against .废物制药:鉴定热解副产物作为抗. 的抗真菌剂
J Biomol Struct Dyn. 2023;41(24):15386-15399. doi: 10.1080/07391102.2023.2188960. Epub 2023 Mar 16.
7
Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine.苯并咪唑及其衍生物作为癌症治疗药物:从传统医学到精准医学的潜在作用。
Acta Pharm Sin B. 2023 Feb;13(2):478-497. doi: 10.1016/j.apsb.2022.09.010. Epub 2022 Sep 21.
8
Synthesis, spectral characterization of pyrazole derived Schiff base analogs: molecular dynamic simulation, antibacterial and DNA binding studies.吡唑衍生席夫碱类似物的合成、光谱表征:分子动力学模拟、抗菌及DNA结合研究
J Biomol Struct Dyn. 2023;41(23):13724-13751. doi: 10.1080/07391102.2023.2179541. Epub 2023 Feb 24.
9
Design, Synthesis, and Bioactivity of Novel Quinazolinone Scaffolds Containing Pyrazole Carbamide Derivatives as Antifungal Agents.含吡唑甲酰胺衍生物的新型喹唑啉酮骨架作为抗真菌剂的设计、合成及生物活性
Curr Issues Mol Biol. 2022 Nov 12;44(11):5605-5621. doi: 10.3390/cimb44110380.
10
Synthesis of new benzimidazole derivatives containing 1,3,4-thiadiazole: their in vitro antimicrobial, in silico molecular docking and molecular dynamic simulations studies.含1,3,4-噻二唑的新型苯并咪唑衍生物的合成:它们的体外抗菌、计算机辅助分子对接和分子动力学模拟研究
SAR QSAR Environ Res. 2022 Nov;33(11):899-914. doi: 10.1080/1062936X.2022.2149620.